DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

India Glycols Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 2d ago·28 Aug 2026, 11:48 am

India Glycols

India Glycols Limited has announced the schedule for its upcoming analyst and institutional investor meet. This event is a key opportunity for the company to engage with the financial community and present its business outlook.

For investors, these meetings are valuable because they provide direct insights into management's strategy and future plans. This information helps in assessing the company's growth potential and making more informed investment decisions.

Investors should watch for updates on the company's performance, expansion plans, and sector trends discussed during the meeting. Following the event, the company is expected to issue a formal press release summarizing the key takeaways.